ICON plc Ordinary Shares ICLR
i
Market datapartial · fetched 2026-11-03T14:43:06.730Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T14:42:43.419801525Z
FundamentalsAlpha Vantage · unavailable
ICON plc Ordinary Shares options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 229.61 | 56.0% | 13.0% | 186.72 | 57.7% | 10.6% |
| 25Δ | 225.09 | 55.3% | 11.2% | 191.18 | 55.5% | 8.9% |
| 30Δ | 220.56 | 54.6% | 9.5% | 194.74 | 55.2% | 7.6% |
| 35Δ | 217.12 | 54.9% | 8.3% | 197.96 | 55.4% | 6.7% |
| 40Δ | 213.82 | 55.4% | 7.3% | 201.09 | 55.3% | 5.8% |
| 45Δ | 210.53 | 55.8% | 6.3% | 204.11 | 54.3% | 5.0% |
| 50Δ | 207.32 | 56.7% | 5.5% | 207.13 | 53.4% | 4.2% |
| 55Δ | 204.11 | 57.7% | 4.8% | 210.16 | 52.5% | 3.4% |
| 60Δ | 200.91 | 58.6% | 4.1% | 213.38 | 52.5% | 2.9% |
| 65Δ | 197.61 | 58.6% | 3.4% | 216.61 | 52.4% | 2.4% |
| 70Δ | 194.19 | 58.3% | 2.7% | 219.83 | 52.4% | 1.8% |
| 75Δ | 190.44 | 58.9% | 2.2% | 223.92 | 52.3% | 1.4% |
| 80Δ | 186.35 | 59.0% | 1.7% | 228.05 | 52.2% | 1.0% |
20Δ
- Pseudo strike
- 229.61
- IV
- 56.0%
- B/E move
- 13.0%
- Pseudo strike
- 186.72
- IV
- 57.7%
- B/E move
- 10.6%
25Δ
- Pseudo strike
- 225.09
- IV
- 55.3%
- B/E move
- 11.2%
- Pseudo strike
- 191.18
- IV
- 55.5%
- B/E move
- 8.9%
30Δ
- Pseudo strike
- 220.56
- IV
- 54.6%
- B/E move
- 9.5%
- Pseudo strike
- 194.74
- IV
- 55.2%
- B/E move
- 7.6%
35Δ
- Pseudo strike
- 217.12
- IV
- 54.9%
- B/E move
- 8.3%
- Pseudo strike
- 197.96
- IV
- 55.4%
- B/E move
- 6.7%
40Δ
- Pseudo strike
- 213.82
- IV
- 55.4%
- B/E move
- 7.3%
- Pseudo strike
- 201.09
- IV
- 55.3%
- B/E move
- 5.8%
45Δ
- Pseudo strike
- 210.53
- IV
- 55.8%
- B/E move
- 6.3%
- Pseudo strike
- 204.11
- IV
- 54.3%
- B/E move
- 5.0%
50Δ
- Pseudo strike
- 207.32
- IV
- 56.7%
- B/E move
- 5.5%
- Pseudo strike
- 207.13
- IV
- 53.4%
- B/E move
- 4.2%
55Δ
- Pseudo strike
- 204.11
- IV
- 57.7%
- B/E move
- 4.8%
- Pseudo strike
- 210.16
- IV
- 52.5%
- B/E move
- 3.4%
60Δ
- Pseudo strike
- 200.91
- IV
- 58.6%
- B/E move
- 4.1%
- Pseudo strike
- 213.38
- IV
- 52.5%
- B/E move
- 2.9%
65Δ
- Pseudo strike
- 197.61
- IV
- 58.6%
- B/E move
- 3.4%
- Pseudo strike
- 216.61
- IV
- 52.4%
- B/E move
- 2.4%
70Δ
- Pseudo strike
- 194.19
- IV
- 58.3%
- B/E move
- 2.7%
- Pseudo strike
- 219.83
- IV
- 52.4%
- B/E move
- 1.8%
75Δ
- Pseudo strike
- 190.44
- IV
- 58.9%
- B/E move
- 2.2%
- Pseudo strike
- 223.92
- IV
- 52.3%
- B/E move
- 1.4%
80Δ
- Pseudo strike
- 186.35
- IV
- 59.0%
- B/E move
- 1.7%
- Pseudo strike
- 228.05
- IV
- 52.2%
- B/E move
- 1.0%
Options history
Table
| Date | IV (%) |
|---|---|
| 51.43% | |
| 50.61% | |
| 48.09% | |
| 48.38% | |
| 48.26% | |
| 46.37% | |
| 44.54% | |
| 42.13% | |
| 43.98% | |
| 48.20% | |
| 47.42% | |
| 47.82% | |
| 44.97% | |
| 45.85% | |
| 46.12% | |
| 44.81% | |
| 45.06% | |
| 45.48% | |
| 46.26% | |
| 47.35% | |
| 46.48% | |
| 46.01% | |
| 45.81% | |
| 48.59% | |
| 49.15% | |
| 47.98% | |
| 46.61% | |
| 49.17% | |
| 50.40% | |
| 50.98% | |
| 51.74% | |
| 48.32% | |
| 47.83% | |
| 47.64% | |
| 48.23% | |
| 50.36% | |
| 48.55% | |
| 50.56% | |
| 49.36% | |
| 49.76% | |
| 50.73% | |
| 49.61% | |
| 50.08% | |
| 51.37% | |
| 51.41% | |
| 49.62% | |
| 49.41% | |
| 51.81% | |
| 52.25% | |
| 56.64% | |
| 54.28% | |
| 54.45% | |
| 54.52% | |
| 53.98% | |
| 54.95% | |
| 54.56% | |
| 56.05% | |
| 53.54% | |
| 44.85% | |
| 44.44% | |
| 47.07% |
Diagnostics & Research
IDXX
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal…
More →ILMN
Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and…
More →IMDX
OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California.
More →IQV
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is…
More →LH
Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American company headquartered in Burlington, North Carolina. It operates one of the largest…
More →MEDP
Description unavailable
More →